A Registry Study of 24-Hour Ambulatory Blood Pressure Monitoring and Its Impact on Cardiovascular Outcomes in Ten Thousand Patients with Hypertension

What this Trial Is About

Hypertension is a common and serious cardiovascular condition that can lead to stroke, heart attack, and heart failure. In China, the control rate of hypertension is low despite its high prevalence, with only a small percentage of patients achieving proper management. This research aims to improve hypertension management by using 24-hour ambulatory blood pressure (ABP) monitoring, which provides a more accurate and comprehensive assessment of blood pressure in daily life compared to traditional office measurements. The study investigates differences in cardiovascular outcomes based on how well ABP is controlled among patients nationwide. The study involves the prospective registration of hypertensive patients who have undergone 24-hour ABP monitoring using validated equipment. Participants must be clinically diagnosed with hypertension and treated with antihypertensive drugs. Data on patients' disease history and recent blood biochemical tests are collected. The study promotes the use of ABP monitoring as a preferred method for diagnosing and managing hypertension to reduce cardiovascular risks effectively. Participants will be followed for up to three years to track major cardiovascular and cerebrovascular events or death related to these conditions. Researchers will monitor and assess patients' blood pressure control and collect clinical information to evaluate how ABP management influences cardiovascular outcomes. The study emphasizes long-term observation to provide insights that may improve hypertension care and reduce heart and brain-related complications.

A Registry Study on the "Action of Controlling Ambulatory Blood Pressure to Target in Ten Thousand Patients"